UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist

Annals of oncology, 2013-01, Vol.24 (1), p.14-20

2013

Volltextzugriff (PDF)

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Investigational new drugs, 2016-12, Vol.34 (6), p.740-749

2016

Volltextzugriff (PDF)

Integration and sensory experience-dependent survival of newly-generated neurons in the accessory olfactory bulb of female mice

The European journal of neuroscience, 2009-02, Vol.29 (4), p.679-692

2009

Volltextzugriff (PDF)

Phase II efficacy and safety data for the MET inhibitor tepotinib in patients (pts) with sorafenib-treated advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2018-10, Vol.29, p.viii235-viii235

2018

Volltextzugriff (PDF)

BDNF/ TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways

The European journal of neuroscience, 2007-10, Vol.26 (7), p.1780-1790

2007

Volltextzugriff (PDF)

Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib

Annals of oncology, 2018-11, Vol.29, p.ix48-ix48

2018

Volltextzugriff (PDF)

Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968)

British journal of clinical pharmacology, 2015-07, Vol.80 (1), p.128-138

2015

Volltextzugriff (PDF)

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii413-viii413

2018

Volltextzugriff (PDF)

Carnosine-related dipeptides in the mammalian brain

Progress in neurobiology, 1999-11, Vol.59 (4), p.333-353

1999

Volltextzugriff (PDF)

PD-020Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii109-ii109

2016

Volltextzugriff (PDF)

Expression and localization of the calmodulin-binding protein neurogranin in the adult mouse olfactory bulb

Journal of comparative neurology (1911), 2009-12, Vol.517 (5), p.683-694

2009

Volltextzugriff (PDF)

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

Annals of oncology, 2009-04, Vol.20 (4), p.741-745

2009

Volltextzugriff (PDF)

Transitory and activity-dependent expression of neurogranin in olfactory bulb tufted cells during mouse postnatal development

Journal of comparative neurology (1911), 2012-10, Vol.520 (14), p.3055-3069

2012

Volltextzugriff (PDF)

Transitory and activity-dependent expression of neurogranin in olfactory bulb tufted cells during mouse postnatal development

Journal of comparative neurology (1911), 2012-10, Vol.520 (14), p.Spc1-Spc1

2012

Volltextzugriff (PDF)

Cell Migration in the Rostral Migratory Stream

Chemical senses, 2002-07, Vol.27 (6), p.581-582

2002

Volltextzugriff (PDF)

Hepatocyte Growth Factor/Scatter Factor Facilitates Migration of GN-11 Immortalized LHRH Neurons

Endocrinology (Philadelphia), 2002-09, Vol.143 (9), p.3306-3315

2002

Volltextzugriff (PDF)

Chain formation and glial tube assembly in the shift from neonatal to adult subventricular zone of the rodent forebrain

Journal of comparative neurology (1911), 2005-07, Vol.487 (4), p.407-427

2005

Volltextzugriff (PDF)

Developmental regulation of metabotropic glutamate receptor 1 splice variants in olfactory bulb mitral cells

Journal of neuroscience research, 2009-02, Vol.87 (2), p.369-379

2009

Volltextzugriff (PDF)

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.447-455

2011

Volltextzugriff (PDF)

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

JOURNAL OF CLINICAL ONCOLOGY, 2008, Vol.26 (15_suppl), p.1057-1057

2008

Volltextzugriff (PDF)

83P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

Annals of oncology, 2022-11, Vol.33, p.S1465-S1466

2022

Volltextzugriff (PDF)

67O Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

Annals of oncology, 2022-11, Vol.33, p.S1456-S1456

2022

Volltextzugriff (PDF)

714P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

Annals of oncology, 2022-09, Vol.33, p.S869-S870

2022

Volltextzugriff (PDF)

Carnosine-related dipeptides in neurons and glia

Biochemistry (Moscow), 2000-07, Vol.65 (7), p.824-833

2000

Volltextzugriff (PDF)

152OEfficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Englisch
(287)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(144)
Humans
(87)
Female
(62)
Animals
(58)
Biological And Medical Sciences
(54)
Male
(53)
Adult
(36)
Middle Aged
(36)
Fundamental And Applied Biological Sciences. Psychology
(35)
Neurosciences
(30)
Neurosciences & Neurology
(30)
Aged
(25)
Ophthalmology
(25)
Immunohistochemistry
(24)
Social Sciences
(24)
Medical Sciences
(23)
Mice
(23)
Oncology
(17)
Psychology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Integration and sensory experience-dependent survival of newly-generated neurons in the accessory olfactory bulb of female mice

Phase II efficacy and safety data for the MET inhibitor tepotinib in patients (pts) with sorafenib-treated advanced hepatocellular carcinoma (HCC)

BDNF/ TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways

Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib

Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968)

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Carnosine-related dipeptides in the mammalian brain

PD-020Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib

Expression and localization of the calmodulin-binding protein neurogranin in the adult mouse olfactory bulb

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

Transitory and activity-dependent expression of neurogranin in olfactory bulb tufted cells during mouse postnatal development

Transitory and activity-dependent expression of neurogranin in olfactory bulb tufted cells during mouse postnatal development

Cell Migration in the Rostral Migratory Stream

Hepatocyte Growth Factor/Scatter Factor Facilitates Migration of GN-11 Immortalized LHRH Neurons

Chain formation and glial tube assembly in the shift from neonatal to adult subventricular zone of the rodent forebrain

Developmental regulation of metabotropic glutamate receptor 1 splice variants in olfactory bulb mitral cells

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

83P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

67O Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

714P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

Carnosine-related dipeptides in neurons and glia

152OEfficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib

Aktive Filter

Suchergebnisse filtern